Effectiveness of Umonium38 against Burkholderia pseudomallei, Escherichia coli, Pseudomonas aeruginosa and Methicillin-Resistant Staphylococcus aureus (MRSA)

Abstract Aims We investigated the antibacterial efficacy of Umonium38 and Virkon® against Burkholderia pseudomallei, Escherichia coli, Pseudomonas aeruginosa and Methicillin-Resistant Staphylococcus aureus (MRSA) up to 14 days following treatment. Methods and results Umonium38 was diluted to 0.5%, 1...

全面介紹

書目詳細資料

Principais autores:	Soiratchaneekorn Ruanchaiman, Premjit Amornchai, Vanaporn Wuthiekanun, Sayan Langla, Peerapol Maroongruang, Khanh Kim Le, Stuart D. Blacksell
格式:	Artigo
語言:	Inglês
出版:	BMC 2024-02-01
叢編:	BMC Infectious Diseases
主題:	Umonium38 Virkon Bacterial viability Disinfectant
在線閱讀:	https://doi.org/10.1186/s12879-024-09102-9
標簽:	添加標簽 沒有標簽, 成為第一個標記此記錄!